152 related articles for article (PubMed ID: 25586981)
21. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders.
Pedreira CE; Costa ES; Almeida J; Fernandez C; Quijano S; Flores J; Barrena S; Lecrevisse Q; Van Dongen JJ; Orfao A;
Cytometry A; 2008 Dec; 73A(12):1141-50. PubMed ID: 18836994
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.
Böttcher S; Ritgen M; Pott C; Brüggemann M; Raff T; Stilgenbauer S; Döhner H; Dreger P; Kneba M
Leukemia; 2004 Oct; 18(10):1637-45. PubMed ID: 15343348
[TBL] [Abstract][Full Text] [Related]
23. Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas.
Kato H; Yamamoto K; Oki Y; Ine S; Taji H; Chihara D; Kagami Y; Seto M; Morishima Y
Leukemia; 2012 Jan; 26(1):166-9. PubMed ID: 21818114
[No Abstract] [Full Text] [Related]
24. [Minimal residual disease detection in acute leukemia patients by flow cytometric assay of cross-lineage antigen expression].
Cho YU; Park CJ; Cha CH; Chi HS; Jang S; Kim MJ; Lee KH; Lee JH; Lee JH; Seo JJ; Im HJ
Korean J Lab Med; 2010 Dec; 30(6):533-9. PubMed ID: 21157135
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry.
Amiot C; Angelot-Delettre F; Zver T; Alvergnas-Vieille M; Saas P; Garnache-Ottou F; Roux C
Hum Reprod; 2013 Aug; 28(8):2157-67. PubMed ID: 23633552
[TBL] [Abstract][Full Text] [Related]
26. Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma.
Zare H; Bashashati A; Kridel R; Aghaeepour N; Haffari G; Connors JM; Gascoyne RD; Gupta A; Brinkman RR; Weng AP
Am J Clin Pathol; 2012 Jan; 137(1):75-85. PubMed ID: 22180480
[TBL] [Abstract][Full Text] [Related]
27. Minimal residual disease studies by flow cytometry in acute leukemia.
Campana D; Coustan-Smith E
Acta Haematol; 2004; 112(1-2):8-15. PubMed ID: 15178999
[TBL] [Abstract][Full Text] [Related]
28. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ
Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079
[TBL] [Abstract][Full Text] [Related]
29. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
[TBL] [Abstract][Full Text] [Related]
30. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.
Neale GA; Coustan-Smith E; Stow P; Pan Q; Chen X; Pui CH; Campana D
Leukemia; 2004 May; 18(5):934-8. PubMed ID: 15029212
[TBL] [Abstract][Full Text] [Related]
33. Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.
Fossat C; Roussel M; Arnoux I; Asnafi V; Brouzes C; Garnache-Ottou F; Jacob MC; Kuhlein E; Macintyre-Davi E; Plesa A; Robillard N; Tkaczuk J; Ifrah N; Dombret H; Béné MC; Baruchel A; Garand R;
Cytometry B Clin Cytom; 2015 Jan; 88(1):21-9. PubMed ID: 25363877
[TBL] [Abstract][Full Text] [Related]
34. A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma.
Medd PG; Clark N; Leyden K; Turner S; Strefford JA; Butler C; Collins GP; Roberts DJ; Atoyebi W; Hatton CS
Cytometry B Clin Cytom; 2011; 80(4):230-7. PubMed ID: 21462308
[TBL] [Abstract][Full Text] [Related]
35. SOX11 as a minimal residual disease marker for Mantle cell lymphoma.
Simonsen AT; Sørensen CD; Ebbesen LH; Bødker JS; Bentzen HH; Nyvold CG
Leuk Res; 2014 Aug; 38(8):918-24. PubMed ID: 24878000
[TBL] [Abstract][Full Text] [Related]
36. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
Sørensen CD; Jørgensen JM; Nederby L; Hokland P; Nyvold CG
J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
[TBL] [Abstract][Full Text] [Related]
37. A highly sensitive and specific qPCR assay for quantification of the biomarker SOX11 in mantle cell lymphoma.
Hamborg KH; Bentzen HH; Grubach L; Hokland P; Nyvold CG
Eur J Haematol; 2012 Nov; 89(5):385-94. PubMed ID: 22827557
[TBL] [Abstract][Full Text] [Related]
38. [A case report of misdiagnosed mantle cell lymphoma].
Yu H; Xu W; Wu YJ; Cheng YX; Qiu HR; Zhang SJ; Sheng RL; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1112-6. PubMed ID: 17956702
[TBL] [Abstract][Full Text] [Related]
39. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
40. The role of SOX11 in mantle cell lymphoma.
Lu TX; Li JY; Xu W
Leuk Res; 2013 Nov; 37(11):1412-9. PubMed ID: 24001358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
